Nithya Desikan, Chief Commercial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 70,362 shares at $22.79 ($1.6M) on 2019-12-27, disclosed to the SEC on 2019-12-31.
Open-market sale of $1.6M RYTM by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.79 | 35,181 | $802K | 50.0% |
| 2 | $22.79 | 35,181 | $802K | 50.0% |
| Total | $22.79 avg | 70,362 | $1.6M | 100% |